Original title: From RNA design to delivery: Computational strategies for functional RNA therapeutics
Yiming Wang, Shengxin Tong, Xin Wang, Xiaowen Jin +2 · August 2026
RNA treatments can fight diseases by controlling how cells make proteins and read genes. However, three main problems slow down their medical use. RNA breaks down too quickly, doctors need a way to control its activity, and getting it into cells efficiently is hard. To solve this, researchers use computers. Computational tools predict RNA shapes and screen through sequences to optimize how molecules behave. Data-driven methods also help design better delivery vehicles to carry RNA safely to its target. By simulating RNA sequence, structure, and delivery together, these tools speed up the development of better therapies. In short, using algorithms to guide RNA and delivery systemA method or carrier, like a nanoparticle, used to transport RNA drugs to the right cells in the body. design creates more stable, effective treatments that could improve future clinical medicine.
Imagine you want to send a fragile gift to a friend across a big city. The gift might break, you need it to arrive at exactly the right time, and you don't have a reliable courier. Normally you'd just pack it and hope. Here, you use a computer to redesign the gift so it's stronger, and also to pick the perfect delivery route and vehicle from thousands of options. In this paper, the gift is an RNA drug, the city is the body, and the computational methods choose both the best RNA sequence and the best delivery system together.
RNA drugs can precisely turn genes on or off, offering new treatments for many diseases. But RNA is fragile, hard to control, and tough to get into cells. Computational methods speed up solving these problems, making RNA therapies more likely to reach patients.
As a review, this paper does not present new experimental results or validate any specific computational method. The future directions discussed are speculative, and clinical translation of these approaches remains unproven. The abstract does not compare the performance of different computational strategies or quantify their success rates.
Ask anything about this paper. Answers come from its abstract, and say so when the abstract doesn't cover your question.
From RNA design to delivery: Computational strategies for functional RNA therapeutics — Yiming Wang, Shengxin Tong, Xin Wang et al. — Bioactive materials — doi:10.1016/j.bioactmat.2026.08.045
Abstract licence: CC BY
Explanation generated by Synthesis from the abstract — it is not the original paper.